does medicaid cover glp-1 drugs Rhode Island considers ending coverage of for weight loss • Rhode Island Current Medicaid Coverage of and Spending

Across the dataset, a few patterns stood out: Zepboundposts mention fatigue, constipation, and hair thinning more than any other drug

Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Its no secret that GLP-1 medications help people lose weight

This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.